Farms.com Home   News

Empowering Farm Bureau Women at the ACE Summit

By Farms.com

The Women’s ACE Summit, a premier event tailored for Farm Bureau women, is scheduled for June 3-5 in Washington, D.C. This summit, building on the legacy of the Farm Bureau Women’s D.C. Fly-In, is designed to foster a deeper understanding of advocacy and empowerment within the agricultural community.

Over two days, the summit will offer a series of national learning sessions and hands-on advocacy training opportunities. These sessions are intended to equip women in agriculture with the knowledge and skills necessary to effectively advocate for their interests and lead within their communities.

With the registration open until May 3, participants are encouraged to secure their spots early, as the event is capped at 200 attendees. The summit not only serves as a training ground but also as a networking hub, allowing participants to build connections and share experiences with fellow Farm Bureau women from across the nation.

The agenda includes engaging keynote addresses and breakout sessions that cover a range of topics relevant to modern agricultural practices and challenges. Additionally, the event features visits to Capitol Hill, where participants can practice their advocacy skills.

Located at the Holiday Inn Capitol with activities also planned at the nearby headquarters office, the summit is strategically placed for easy access to the heart of U.S. policymaking. This biennial event is supported by various leaders in the agricultural sector and aims to highlight and address the unique role of women in advancing the agricultural agenda through informed advocacy and leadership.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.